Group One Trading’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.3K | Buy |
1,394
+590
| +73% | +$4.37K | ﹤0.01% | 1568 |
|
|
2025
Q1 | $6.92K | Sell |
804
-1,287
| -62% | -$11.1K | ﹤0.01% | 1522 |
|
|
2024
Q4 | $74.8K | Buy |
2,091
+788
| +60% | +$28.2K | ﹤0.01% | 1134 |
|
|
2024
Q3 | $61.6K | Buy |
1,303
+364
| +39% | +$17.2K | ﹤0.01% | 951 |
|
|
2024
Q2 | $47.2K | Buy |
+939
| New | +$47.2K | ﹤0.01% | 996 |
|
|
2024
Q1 | – | Sell |
-1,243
| Closed | -$72.1K | – | 2695 |
|
|
2023
Q4 | $72.1K | Sell |
1,243
-440
| -26% | -$25.5K | ﹤0.01% | 994 |
|
|
2023
Q3 | $53.4K | Sell |
1,683
-4,729
| -74% | -$150K | ﹤0.01% | 1070 |
|
|
2023
Q2 | $527K | Buy |
6,412
+6,328
| +7,533% | +$520K | ﹤0.01% | 471 |
|
|
2023
Q1 | $8.63K | Buy |
+84
| New | +$8.63K | ﹤0.01% | 1343 |
|
|
2022
Q4 | – | Sell |
-30
| Closed | -$5K | – | 2761 |
|
|
2022
Q3 | $5K | Sell |
30
-51
| -63% | -$8.5K | ﹤0.01% | 1695 |
|
|
2022
Q2 | $9K | Sell |
81
-644
| -89% | -$71.6K | ﹤0.01% | 1667 |
|
|
2022
Q1 | $72K | Buy |
725
+672
| +1,268% | +$66.7K | ﹤0.01% | 1333 |
|
|
2021
Q4 | $8K | Sell |
53
-101
| -66% | -$15.2K | ﹤0.01% | 1919 |
|
|
2021
Q3 | $36K | Buy |
+154
| New | +$36K | ﹤0.01% | 1617 |
|
|
2021
Q2 | – | Sell |
-355
| Closed | -$144K | – | 2671 |
|
|
2021
Q1 | $144K | Buy |
355
+195
| +122% | +$79.1K | ﹤0.01% | 1113 |
|
|
2020
Q4 | $107K | Buy |
+160
| New | +$107K | ﹤0.01% | 999 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 2133 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 1950 |
|